Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists

Objective Clinically nonfunctioning pituitary adenoma (NFPA) remains the only pituitary tumor subtype for which no effective medical therapy is available or recommended. We evaluated dopamine agonist (DA) therapy for preventing growth of postsurgical pituitary tumor remnants. Design The study design...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of endocrinology 2016-07, Vol.175 (1), p.63-72
Hauptverfasser:	Greenman, Y, Cooper, O, Yaish, I, Robenshtok, E, Sagiv, N, Jonas-Kimchi, T, Yuan, X, Gertych, A, Shimon, I, Ram, Z, Melmed, S, Stern, N
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenoma Adenoma - diagnostic imaging Adenoma - drug therapy Adenoma - metabolism Adult Aged Brain tumors Bromocriptine - therapeutic use Clinical Study Disease Progression Dopamine Dopamine Agonists - therapeutic use Dopamine D2 receptors Ergolines - therapeutic use Female Humans Immunohistochemistry Magnetic Resonance Imaging Male Middle Aged Patients Pituitary Pituitary Neoplasms - diagnostic imaging Pituitary Neoplasms - drug therapy Pituitary Neoplasms - metabolism Polymerase chain reaction Radiation therapy Receptors, Dopamine - metabolism Receptors, Estrogen - metabolism Surgery Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!